221 related articles for article (PubMed ID: 23018460)
21. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients.
Lowry PA; Shultz LD; Greiner DL; Hesselton RM; Kittler EL; Tiarks CY; Rao SS; Reilly J; Leif JH; Ramshaw H; Stewart FM; Quesenberry PJ
Biol Blood Marrow Transplant; 1996 Feb; 2(1):15-23. PubMed ID: 9078350
[TBL] [Abstract][Full Text] [Related]
22. Histopathological characteristics of human non-tumor thyroid tissues in a long-term model of adenomatous goiter xenografts in the NOD/Shi-scid, IL-2Rγ(null) mouse.
Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
Exp Toxicol Pathol; 2014 Jul; 66(4):203-9. PubMed ID: 24589354
[TBL] [Abstract][Full Text] [Related]
23. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
24. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R
J Immunol; 2005 May; 174(10):6477-89. PubMed ID: 15879151
[TBL] [Abstract][Full Text] [Related]
25. Phytohemagglutinin-activated human T cells induce lethal graft-versus-host disease in cyclophosphamide and anti-CD122 conditioned NOD/SCID mice.
Hu Y; Gu Y; Cui Q; Fu H; Sheng L; Wu K; Liu L; Fu S; Yu X; Huang H
Ann Hematol; 2012 Nov; 91(11):1803-12. PubMed ID: 22699803
[TBL] [Abstract][Full Text] [Related]
26. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice.
Hamada K; Monnai M; Kawai K; Nishime C; Kito C; Miyazaki N; Ohnishi Y; Nakamura M; Suemizu H
Int J Oncol; 2008 Jan; 32(1):153-9. PubMed ID: 18097554
[TBL] [Abstract][Full Text] [Related]
27. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
[TBL] [Abstract][Full Text] [Related]
28. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice.
Takajo I; Umeki K; Morishita K; Yamamoto I; Kubuki Y; Hatakeyama K; Kataoka H; Okayama A
Int J Cancer; 2007 Nov; 121(10):2205-11. PubMed ID: 17657714
[TBL] [Abstract][Full Text] [Related]
29. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models.
Ito M; Kobayashi K; Nakahata T
Curr Top Microbiol Immunol; 2008; 324():53-76. PubMed ID: 18481452
[TBL] [Abstract][Full Text] [Related]
30. Multiple integrations of human T-lymphotropic virus type 1 proviruses in the engrafted cells from the asymptomatic carriers in NOD/SCID/gammacnull mice.
Yamamoto I; Takajo I; Umeki K; Morishita K; Hatakeyama K; Kataoka H; Nomura H; Okayama A
Intervirology; 2010; 53(4):229-39. PubMed ID: 20357492
[TBL] [Abstract][Full Text] [Related]
31. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
32. Innate Response to Human Cancer Cells with or without IL-2 Receptor Common γ-Chain Function in NOD Background Mice Lacking Adaptive Immunity.
Nishime C; Kawai K; Yamamoto T; Katano I; Monnai M; Goda N; Mizushima T; Suemizu H; Nakamura M; Murata M; Suematsu M; Wakui M
J Immunol; 2015 Aug; 195(4):1883-90. PubMed ID: 26170385
[TBL] [Abstract][Full Text] [Related]
33. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.
Greiner DL; Shultz LD; Yates J; Appel MC; Perdrizet G; Hesselton RM; Schweitzer I; Beamer WG; Shultz KL; Pelsue SC
Am J Pathol; 1995 Apr; 146(4):888-902. PubMed ID: 7717456
[TBL] [Abstract][Full Text] [Related]
34. Comparison of human cord blood engraftment between immunocompromised mouse strains.
McDermott SP; Eppert K; Lechman ER; Doedens M; Dick JE
Blood; 2010 Jul; 116(2):193-200. PubMed ID: 20404133
[TBL] [Abstract][Full Text] [Related]
35. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
[TBL] [Abstract][Full Text] [Related]
36. Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.
Wulf-Goldenberg A; Keil M; Fichtner I; Eckert K
Tissue Cell; 2012 Apr; 44(2):80-6. PubMed ID: 22197619
[TBL] [Abstract][Full Text] [Related]
37. Improved engraftment of human peripheral blood mononuclear cells in NOG MHC double knockout mice generated using CRISPR/Cas9.
Ka Y; Katano I; Nishinaka E; Welcker J; Mochizuki M; Kawai K; Goto M; Tomiyama K; Ogura T; Yamamoto T; Ito M; Ito R; Takahashi R
Immunol Lett; 2021 Jan; 229():55-61. PubMed ID: 33253759
[TBL] [Abstract][Full Text] [Related]
38. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
Zheng Y; Sun A; Han ZC
Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
[TBL] [Abstract][Full Text] [Related]
39. Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells.
Yacoub-Youssef H; Marcheix B; Calise D; Thiers JC; Therville N; Benoist H; Blaes N; Ségui B; Dambrin C; Thomsen M
Transpl Immunol; 2005 Dec; 15(2):157-64. PubMed ID: 16412960
[TBL] [Abstract][Full Text] [Related]
40. A preclinical xenotransplantation animal model to assess human hematopoietic stem cell engraftment.
Angelopoulou MK; Rinder H; Wang C; Burtness B; Cooper DL; Krause DS
Transfusion; 2004 Apr; 44(4):555-66. PubMed ID: 15043572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
